stock · yahoo

Intuitive Surgical, Inc.

ISRG

$345.42
56.91 (-14.15%)
polled · warming up

Below: live stock price for Intuitive Surgical, Inc. (ISRG), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.

Intuitive Surgical, Inc. (ISRG) is a Healthcare company based in United States. Operating in Medical Instruments & Supplies, it employs about 17,021 people. Over the past year ISRG traded between 344.55 and 603.88 USD. Trailing P/E sits near 39.7 on a market cap of about 122.33B USD.

Day
-14.15%
-56.91
Week
-15.08%
-61.36
Month
-15.08%
-61.36
Year
Prev close
$402.33
Volume (24h)
$3.99B
Market cap
$122.33B
Currency
USD

Score

64/ 100 · Solid

Coverage: 7/7
  • Value21
  • Quality78
  • Momentum11
  • Growth56
  • Risk81
  • Dividend100
  • Liquidity100

Composite of public market data. Informational only — not investment advice.

Trend projection

Where the recent trend points if it continues.

DowntrendFit 71%Pace -0.30% per bar
+5 bars+20 bars+60 bars+120 bars
+5 bars
341.433
-1.15%
Bull395.8786
Bear294.4753
+20 bars
336.0073
-2.73%
Bull451.7122
Bear249.9399
+60 bars
333.9315
-3.33%
Bull557.5048
Bear200.0167
+120 bars
333.8556
-3.35%
Bull689.2079
Bear161.7213

Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0331 USD.

Interpretation

Composite signals look solid. Strength: dividend with weakness: momentum. Price sits near the lower third of the recent range, trend is sloping downward.

Descriptive observation — not investment advice.

Score breakdown

Raw values behind each pillar so you can see what the composite is reading.

  • Value
    21/100

    Value looks fragile — driven by P/E (39.7).

    P/E:39.7P/B:7.01PEG:1.81
  • Quality
    78/100

    Quality looks strong — driven by Gross margin (66.77%).

    ROE:17.42%ROA:10.54%Profit margin:28.45%Gross margin:66.77%
  • Momentum
    11/100

    Momentum looks fragile — driven by 52w change (-33.07%).

    52w change:-33.07%
  • Growth
    56/100

    Growth looks mixed — driven by Earnings growth (26.50%).

    Revenue growth:18.50%Earnings growth:26.50%
  • Risk
    81/100

    Risk looks strong — driven by Beta (1.46).

    Beta:1.46Short interest:2.08%
  • Dividend
    100/100

    Dividend looks strong — driven by Payout ratio (0.00%).

    Payout ratio:0.00%
  • Liquidity
    100/100

    Liquidity looks strong — driven by Current ratio (6.43).

    Current ratio:6.43Quick ratio:5.37

Derived from public market data — informational, not investment advice.

Reference levels

Fibonacci retracements and extensions across the recent range.

60 bars

Reference only — not investment advice.

These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.

  • ResistanceFib +161.8% extension
    728.3488 USD
    +110.86% from current
  • ResistanceFib +100% extension
    637.75 USD
    +84.63% from current
  • ResistanceFib +61.8% extension
    581.7488 USD
    +68.42% from current
  • ResistanceFib +27.2% extension
    531.0252 USD
    +53.73% from current
  • ResistanceFib 23.6% retracement
    456.5524 USD
    +32.17% from current
  • ResistanceFib 38.2% retracement
    435.1488 USD
    +25.98% from current
  • ResistanceFib 50% midpoint
    417.85 USD
    +20.97% from current
  • ResistanceFib 61.8% retracement
    400.5512 USD
    +15.96% from current
  • ResistanceFib 78.6% retracement
    375.9224 USD
    +8.83% from current
  • Current
    345.42 USD
  • SupportFib −27.2% extension
    304.6748 USD
    -11.80% from current
  • SupportFib −61.8% extension
    253.9512 USD
    -26.48% from current
  • SupportFib −100% extension
    197.95 USD
    -42.69% from current

Financials

52w high
$603.88
52w low
$344.55
52w change
-33.07%
Day high
$367.15
Day low
$344.55
P/E (TTM)
39.7
Forward P/E
28.79
PEG
1.81
Price / Book
7.01
Beta (5Y)
1.46
Enterprise value
113.69B
EV / Revenue
10.3
EV / EBITDA
27.27
EPS (TTM)
$8.70
Forward EPS
$12.00
Payout ratio
0.00%
Revenue (TTM)
11.03B
EBITDA
4.17B
Total cash
8.63B
Total debt
0
Current ratio
6.43
Quick ratio
5.37
Profit margin
28.45%
Gross margin
66.77%
Return on assets
10.54%
Return on equity
17.42%
Shares outstanding
354.16M
Float
352.03M
Sector: HealthcareIndustry: Medical Instruments & SuppliesHQ: United StatesEmployees: 17.02Kwww.intuitive.com

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Analyst & Risk

Consensus
Buy
Mean rating1.91 / 5
Analysts29
Next earnings2026-07-16
Strong buy 6Buy 16Hold 10Sell 1
Analyst price target
$504.15
Mean target · 29 analysts
+46.0%
upside
Low $324.00Now $345.42High $685.00
Beta (vs S&P 500)
1.46
slightly more volatile
52-week change
-33.07%
Short % of float
2.08%
Short ratio (days)
2.79
Current ratio
6.43
Quick ratio
5.37
ROE
17.42%
ROA
10.54%
PEG ratio
1.81
fair
EV / Revenue
10.3
EV / EBITDA
27.27
Revenue growth
18.50%
Earnings growth
26.50%
EBITDA
4.17B
Total cash
8.63B
Total debt
0
Insider holdings
0.51%
Institutional
90.44%

Recent rating changes

  • 2026-07-17Raymond JamesOutperformOutperformmain
  • 2026-07-17Piper SandlerOverweightOverweightreit
  • 2026-07-17JP MorganOverweightOverweightmain
  • 2026-07-17MizuhoNeutralNeutralmain
  • 2026-07-17Wells FargoOverweightOverweightmain
  • 2026-07-17TD CowenBuyBuymain
  • 2026-07-17Evercore ISI GroupIn-LineIn-Linemain
  • 2026-07-17RBC CapitalOutperformOutperformmain

Recent news

Related

Other assets in this category.

Live discussion

Sign in to join the discussion.

  • No comments yet. Be the first.